Clinical Trial Update: Dose-Escalation Study of Artesunate Patients With IPF [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial of artesunate in idiopathic pulmonary fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Artesunate (artesunate)

Snippet

Sponsor: Joseph C. Wu | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: RECRUITING